Cedars-Sinai identifies genetic variants linked to resistant hypertension
This digest was compiled by AI from multiple sources — links to the originals are below.
Cedars-Sinai researchers have identified genetic variants that may cause resistant hypertension. These variants affect kidney function and blood pressure regulation. The discovery could explain why standard treatments fail for some patients.
Genetic Variants and Hypertension
The study conducted by Cedars-Sinai Medical Center highlights specific genetic variants that are linked to resistant hypertension. These variants were found to influence kidney function, which plays a crucial role in blood pressure regulation. Resistant hypertension is characterized by high blood pressure that remains uncontrolled despite the use of multiple antihypertensive medications. The findings suggest that genetic screening could become an important tool in managing this condition.
Impact on Treatment Approaches
The discovery by Cedars-Sinai researchers could lead to more personalized treatment strategies for patients with resistant hypertension. Current standard therapies often fail to control blood pressure in these patients, who represent a significant portion of those with hypertension. The identification of genetic factors offers a potential pathway for developing targeted therapies. This could improve outcomes for patients who do not respond to conventional medications.
What's Next
Further research is needed to validate these findings and explore potential treatments. It remains unclear how soon genetic screening could be integrated into clinical practice.
1 source
Cedars-Sinai identifies genetic variants linked to resistant hypertension
